tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Emergent BioSolutions sees FY25 revenue $775M-$835M, consensus $799.1M
PremiumThe FlyEmergent BioSolutions sees FY25 revenue $775M-$835M, consensus $799.1M
11d ago
Emergent BioSolutions reports Q3 EPS $1.06 vs. $1.37 last year
Premium
The Fly
Emergent BioSolutions reports Q3 EPS $1.06 vs. $1.37 last year
11d ago
EBS Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
EBS Upcoming Earnings Report: What to Expect?
14d ago
Emergent BioSolutions secures $17M contract modification from BARDA
PremiumThe FlyEmergent BioSolutions secures $17M contract modification from BARDA
2M ago
Emergent BioSolutions Secures $56 Million Contract Modification
Premium
Company Announcements
Emergent BioSolutions Secures $56 Million Contract Modification
2M ago
Emergent BioSolutions: Strategic Positioning and Contract Wins Support Buy Rating Despite Risks
Premium
Ratings
Emergent BioSolutions: Strategic Positioning and Contract Wins Support Buy Rating Despite Risks
2M ago
LSBK, EBS, MNSO: Three AI Analyst Stocks With Over 20% Upside
PremiumMarket NewsLSBK, EBS, MNSO: Three AI Analyst Stocks With Over 20% Upside
2M ago
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer for Inhalational Anthrax Treatment
Premium
Company Announcements
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer for Inhalational Anthrax Treatment
3M ago
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer for Anthrax Treatment
Premium
Company Announcements
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer for Anthrax Treatment
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100